Thailand Point-of-Care Testing (POCT) Market is growing with factors such as the rising prevalence of chronic diseases and rising preference for home healthcare services. The growing popularity of wearable or glucose monitoring devices also acts as a major factor for the market's growth. Improving diagnosis-seeking rates has also given a boom to the Thailand point-of-care testing (POCT) market.
Increasing healthcare expenditure has propelled the demand of the market. However, the high cost of products and rising product recalls have decreased the market's demand.
Thailand Point-of-Care Testing (POCT) Market Scenario
According to Data Bridge Market Research, the market leader is F. Hoffmann-La Roche Ltd. which accounts for an estimated market share of approximately 52.23% in the market. The company has gained outstanding sales by providing iron and folic acid supplements products.
- In January 2018, F. Hoffmann-La Roche Ltd had announced the launch of the cobas Plasma Separation Card. This new solution is a stable and easy-to-use sample collection device for HIV plasma viral load testing. This has raised their sales and product portfolio.
Trends Impacting the Point-of-Care Testing Market
The Thailand point-of-care testing (POCT) market is becoming more competitive with companies like F. Hoffmann-La Roche Ltd., Danaher, and BD. These are the top dominating companies in the point-of-care testing (POCT) market and have launched novel products. Data Bridge Market Research new reports highlight the major growth factors and opportunities in the Thailand point-of-care testing (POCT) market.
For more analysis on the Thailand point-of-care testing (POCT) market request for a briefing with our analysts https://www.databridgemarketresearch.com/jp/speak-to-analyst/?dbmr=thailand-point-of-care-testing-poct-market
Point-of-care testing (POCT) Market Developments
- In April 2021, BD announced that the company would be presenting in virtual investor healthcare conferences,“The Bank of America Securities 2021 Virtual Healthcare Conference” and‘The UBS Global Healthcare Virtual Conference”. This helped company in gaining more customers globally and improved revenue for the future market.
- In April 2020, Danaher announced the completion of the sale of its label-free biomolecular characterization, microcarriers, and particle validation standards. The company sold these ventures to obtain regulatory approval for its acquisition of the GE Biopharma business. This will help the company in the launching of further new services.
- In November 2015, F. Hoffmann-La Roche Ltd had announced that they have launched the CoaguChek Pro II system in countries accepting the CE Mark. This product combines two tests in a single device - the activated partial thromboplastin time (aPTT) test and the prothrombin time (PT) test. This has increased their product pipeline.
Scope of the Point-of-Care Testing (POCT) Market
Thailand point-of-care testing (POCT) market is segmented on the basis of countries into Thailand.
- All country based analysis of the Thailand point-of-care testing (POCT) market is further analyzed based on maximum granularity into further segmentation. On the basis of product, the point-of-care testing (POCT) market is segmented into glucose monitoring products, cardiometabolic testing products, infectious disease testing products, pregnancy and fertility testing products, tumor/cancer marker testing products, urinalysis testing products, cholesterol testing products, hematology testing products, drugs-of-abuse testing products, fecal occult testing products, rapid coagulation testing and other POC products. On the basis of application, the point-of-care testing (POCT) market is segmented into blood transfusion, cardiac monitoring, coagulation, blood glucose, haematology, non- invasive SPO2 monitoring, non- invasive PCO2 monitoring, whole blood analysis, vital sign monitoring and others. On the basis of platform, the point-of-care testing (POCT) market is segmented into lateral flow assays/immunochromatography tests, dipsticks, microfluidics, molecular diagnostics and immunoassays. On the basis of prescription mode, the point-of-care testing (POCT) market is segmented into prescription-based testing and OTC testing. On the basis of testing type, the point-of-care testing (POCT) market is segmented into immunoassays, cell-based assays, nucleic acid amplification testing, clinical chemistry assays and hematology. On the basis of end-user, the point-of-care testing (POCT) market is segmented into hospitals, clinics, laboratories, home care, ambulatory surgery centers and others. On the basis of distribution channel, the point-of-care testing (POCT) market is segmented into direct tender and retail pharmacies.
To know more about the study https://www.databridgemarketresearch.com/jp/reports/thailand-point-of-care-testing-poct-market
Key Pointers Covered in Point-of-care testing (POCT) Market Industry Trends and Forecast to 2028
- Market Size
- Top to Bottom Market Analysis
- Recent Developments for Market Competitors
- Recent Market Value for Different Countries
- Market value and overview of point-of-care testing (POCT) market
- Company profiling of top eight players of point-of-care testing (POCT) market
Key Market Competitors Covered in the Report
- Bio-Rad Laboratories, Inc.
- bioMérieux SA
- Trinity Biotech
- BD.
- EKF Diagnostics
- Abbott
- Quidel Corporation
- Sienco, Inc.
- Danaher
- Chembio Diagnostics,Inc.
- Siemens Healthcare GmbH.
- Nova Biomedical
- PTS Diagnostics
- AccuBioTech Co., Ltd
- Beckman Coulter, Inc.
- F. Hoffmann-La Roche Ltd
- Sekisui Diagnostics
- Instrumentation Laboratory (A Subsidiary Of Werfen),
- Xiamen Biotime Biotechnology Co., Ltd.
- FUJIFILM Thailand Ltd and among others.
Above are the key players covered in the report. To know about more an exhaustive list of point-of-care testing (POCT) companies’, contact us: https://www.databridgemarketresearch.com/jp/toc/?dbmr=thailand-point-of-care-testing-poct-market
Research Methodology: Thailand Point-of-Care Testing (POCT) Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or can drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market timeline analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis, and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Primary Respondents
- Demand Side: Manufacturer, Geneticists, Healthcare Industry, Scientists, Research Laboratories.
- Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers, among others.
Related Reports
- Global Point of Care Molecular Diagnostics Market - Industry Trends and Forecast to 2028
- Global Point of Care Infectious Disease Market - Industry Trends and Forecast to 2028
- Global Point of care (PoC) Lipid Test Market - Industry Trends and Forecast to 2028
Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/jp/report-category/healthcare/
